Natriumchlorid, Viaflo Baxter (Sodium Chloride)

Sodium Chloride, the active ingredient in Natriumchlorid, Viaflo Baxter, is an electrolyte solution presented as an injection solution for intravenous use. It restores extracellular fluid volume and corrects electrolyte imbalances in patients requiring fluid and electrolyte replacement.

GNH USA supplies Natriumchlorid, Viaflo Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Natriumchlorid, Viaflo Baxter is an intravenous electrolyte solution used in conditions affecting fluid balance and electrolyte status. - Fluid and electrolyte replacement: reestablishes plasma volume and normal sodium/chloride concentrations in patients with fluid loss. - Hypovolemia: rapidly expands intravascular volume to improve tissue perfusion. - Dehydration: corrects deficits of water and electrolytes caused by illness, surgery, or inadequate intake.

Adverse reactions may occur with intravenous administration of sodium chloride solutions.

Common Side Effects: - Injection site pain or irritation. - Mild hypernatremia leading to thirst. - Transient hypertension due to volume expansion. - Fluid overload in susceptible patients.

Serious or Rare Side Effects: - Severe hypernatremia causing neurological symptoms. - Pulmonary edema from excessive fluid administration. - Anaphylactic or severe allergic reactions. - Cardiac arrhythmias secondary to electrolyte imbalance. - Metabolic acidosis in rare cases.

Use of Natriumchlorid, Viaflo Baxter requires careful clinical assessment and monitoring. - Assess fluid status: evaluate patient volume status before infusion. - Monitor electrolytes: check serum sodium and chloride levels regularly. - Avoid rapid infusion in cardiac failure: infuse slowly and monitor hemodynamics. - Use caution in renal impairment: adjust volume and monitor renal function. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Intravenous sodium chloride may interact with other therapies affecting fluid and electrolyte balance.

Major Interactions (Avoid): - Concurrent hypertonic saline: risk of severe hypernatremia. - Loop diuretics: may exacerbate electrolyte shifts and volume depletion. - ACE inhibitors combined with potassium supplements: potential for electrolyte disturbances.

Moderate Interactions (Monitor Closely): - IV fluids containing potassium: monitor serum potassium levels. - Blood product transfusions: watch for changes in electrolyte concentrations. - Corticosteroids: may influence fluid retention and electrolyte balance.